Cynthia Smith

Insider Reports History

Location
508 Wrangler Drive, Suite 100, Coppell, TX
Signature
/s/ William Cook, as attorney-in-fact for Cynthia Smith
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cynthia Smith:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AGIOS PHARMACEUTICALS, INC. Director Common stock 12.4K $487K $39.27 Aug 11, 2025 Direct
Akebia Therapeutics, Inc. Director Common Stock 161K $422K $2.62 Jun 10, 2025 Direct
AGIOS PHARMACEUTICALS, INC. Director Restricted stock units 0 $98.4K $42.75 Aug 11, 2025 Direct
Spero Therapeutics, Inc. Director Common Stock 75K $54.8K $0.73 Jun 12, 2025 Direct
Akebia Therapeutics, Inc. Director Stock Option (Right to buy) 53.6K Jun 10, 2025 Direct
Protara Therapeutics, Inc. Director Stock Option (Right to Buy) 24K Jun 12, 2025 Direct
AGIOS PHARMACEUTICALS, INC. Director Stock options (right to buy) 15.8K Jun 18, 2025 Direct
Tvardi Therapeutics, Inc. Director Stock Option (right to buy) 12K Apr 17, 2025 Direct
Dicerna Pharmaceuticals Inc Director Common Stock 0 $38.25 Dec 28, 2021 Direct
Dicerna Pharmaceuticals Inc Director Director Stock Option (Right to Buy) 0 Dec 28, 2021 Direct
Dicerna Pharmaceuticals Inc Director Restricted Stock Units 0 Dec 28, 2021 Direct

Insider Reports Filed by Cynthia Smith

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AGIO AGIOS PHARMACEUTICALS, INC. Aug 11, 2025 2 $0 4 Aug 13, 2025 Director
AGIO AGIOS PHARMACEUTICALS, INC. Jun 18, 2025 4 $0 4 Jun 23, 2025 Director
SPRO Spero Therapeutics, Inc. Jun 12, 2025 1 $0 4 Jun 16, 2025 Director
TARA Protara Therapeutics, Inc. Jun 12, 2025 1 $0 4 Jun 13, 2025 Director
AKBA Akebia Therapeutics, Inc. Jun 10, 2025 2 $0 4 Jun 11, 2025 Director
TVRD Tvardi Therapeutics, Inc. Apr 17, 2025 1 $0 4 Apr 21, 2025 Director
TVRD Tvardi Therapeutics, Inc. Apr 15, 2025 0 $0 3 Apr 17, 2025 Director
AGIO AGIOS PHARMACEUTICALS, INC. Aug 11, 2024 2 $0 4 Aug 13, 2024 Director
AGIO AGIOS PHARMACEUTICALS, INC. Jun 20, 2024 2 $0 4 Jun 24, 2024 Director
AGIO AGIOS PHARMACEUTICALS, INC. Jun 13, 2024 2 $0 4 Jun 17, 2024 Director
TARA Protara Therapeutics, Inc. Jun 7, 2024 1 $0 4 Jun 10, 2024 Director
AKBA Akebia Therapeutics, Inc. Jun 6, 2024 2 $0 4 Jun 10, 2024 Director
SPRO Spero Therapeutics, Inc. May 29, 2024 1 $0 4 May 30, 2024 Director
SPRO Spero Therapeutics, Inc. Oct 5, 2023 1 $0 4 Oct 10, 2023 Director
AGIO AGIOS PHARMACEUTICALS, INC. Aug 11, 2023 2 $0 4 Aug 15, 2023 Director
AGIO AGIOS PHARMACEUTICALS, INC. Jun 13, 2023 2 $0 4 Jun 15, 2023 Director
TARA Protara Therapeutics, Inc. Jun 7, 2023 1 $0 4 Jun 8, 2023 Director
AKBA Akebia Therapeutics, Inc. Jun 6, 2023 2 $0 4 Jun 8, 2023 Director
SPRO Spero Therapeutics, Inc. Sep 15, 2022 1 $0 4 Sep 19, 2022 Director
AGIO AGIOS PHARMACEUTICALS, INC. Aug 11, 2022 2 $0 4 Aug 15, 2022 Director
AGIO AGIOS PHARMACEUTICALS, INC. Aug 11, 2022 0 $0 3 Aug 15, 2022 Director
AKBA Akebia Therapeutics, Inc. Jun 8, 2022 2 $0 4 Jun 9, 2022 Director
TARA Protara Therapeutics, Inc. Jun 8, 2022 1 $0 4 Jun 9, 2022 Director
DRNA Dicerna Pharmaceuticals Inc Dec 28, 2021 6 -$127K 4 Dec 29, 2021 Director
SPRO Spero Therapeutics, Inc. Aug 17, 2021 1 $0 4 Aug 18, 2021 Director
TARA Protara Therapeutics, Inc. Jun 9, 2021 1 $0 4 Jun 10, 2021 Director
DRNA Dicerna Pharmaceuticals Inc Jun 3, 2021 4 $0 4 Jun 7, 2021 Director
AKBA Akebia Therapeutics, Inc. Jun 2, 2021 2 $0 4 Jun 3, 2021 Director